Bioanalytical Systems (BASI) Swings to Q3 Loss

Bioanalytical Systems (NASDAQ: BASI) reported Q3 EPS of ($0.05), versus $0.16 reported last year. Revenue for the quarter came in at $5.05 million, versus $6.15 million reported last year.

For earnings history and earnings-related data on Bioanalytical Systems (BASI) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan